Frontiers in Drug Safety and Regulation

Frontiers Media S.A.

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Frontiers in Drug Safety and Regulation is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,950 CHF. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Frontiers Media S.A.
ISSN
2674-0869
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
1,950 CHF
Articles in DOAJ
122
Declared review time
15 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2023-11-06
Indexing
DOAJ
APC
1,950 CHF
Declared review time (DOAJ)
15 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

122

Most recent article

last month

Average review time (journal-declared via DOAJ)

15weeks

Works in OpenAlex

114

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

11

i10-index

14

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-03-12
Added to DOAJ
2023-11-06
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Open references deposited at Crossref
99%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9919033103806676
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmacovigilance and Adverse Drug Reactions
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Biosimilars and Bioanalytical Methods
  • Biosimilars and Bioanalytical Methods
  • Pregnancy and Medication Impact
  • Pregnancy and Medication Impact
Show all subjects (50)
  • Drug-Induced Adverse Reactions
  • Drug-Induced Adverse Reactions
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Economics and Policy
  • Artificial Intelligence in Healthcare and Education
  • Pharmaceutical Quality and Counterfeiting
  • COVID-19 Impact on Reproduction
  • Artificial Intelligence in Healthcare and Education
  • Statistical Methods in Clinical Trials
  • COVID-19 Impact on Reproduction
  • Pharmaceutical Quality and Counterfeiting
  • Statistical Methods in Clinical Trials
  • Advanced Causal Inference Techniques
  • Advanced Causal Inference Techniques
  • Vaccine Coverage and Hesitancy
  • Maternal Mental Health During Pregnancy and Postpartum
  • Maternal Mental Health During Pregnancy and Postpartum
  • Vaccine Coverage and Hesitancy
  • Biomedical Ethics and Regulation
  • Asthma and respiratory diseases
  • SARS-CoV-2 and COVID-19 Research
  • Inhalation and Respiratory Drug Delivery
  • Biomedical Ethics and Regulation
  • Pharmacological Effects and Toxicity Studies
  • Biomedical Text Mining and Ontologies
  • SARS-CoV-2 and COVID-19 Research
  • Asthma and respiratory diseases
  • Biomedical Text Mining and Ontologies
  • Pharmacological Effects and Toxicity Studies
  • Inhalation and Respiratory Drug Delivery
  • Rheumatoid Arthritis Research and Therapies
  • Rheumatoid Arthritis Research and Therapies
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Electronic Health Records Systems
  • Electronic Health Records Systems
  • Gastrointestinal motility and disorders
  • Gastrointestinal motility and disorders

Keywords (DOAJ)

  • medicine
  • pharmacogenomics
  • clinical pharmacology and therapeutics

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: